XML 15 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 7 Months Ended 9 Months Ended 12 Months Ended
Jul. 21, 2023
Sep. 30, 2023
Sep. 30, 2024
Jul. 21, 2023
Sep. 30, 2024
Dec. 31, 2023
Cash flows from operating activities:            
Net income (loss)   $ (297,711)   $ (60,678) $ 39,923  
Adjustments to reconcile net income (loss) to net cash used in operating activities:            
Depreciation   21   54 74  
Stock-based compensation expense   2,171   3,235 4,908  
Write-off of acquired in-process research and development   348,000        
Change in fair value of convertible notes $ 13,249   $ 1,878 19,359 170  
Change in fair value of warrants   (1,593) 377   15,376  
Change in fair value of embedded forward purchase agreements and derivative liabilities $ 11,789 15,776 (81) 11,789 19,931  
Change in fair value of contingent consideration   (75,939) 0   (97,464)  
Changes in operating assets and liabilities:            
Prepaid expenses and other current assets   (363)   36 (770)  
Accounts payable   (3,716)   (248) 1,242  
Accrued expenses and other liabilities   (1,701)   4,736 (3,181)  
Other assets and liabilities   (6)   (28) 120  
Net cash used in operating activities   (15,061)   (21,745) (19,671)  
Cash flows from financing activities:            
Proceeds from issuance of convertible notes       14,000 15,000  
Aggregate gross proceeds         50  
Net cash provided by financing activities       14,000 15,050  
Net decrease in cash   $ (15,061)   $ (7,745) (4,621)  
Cash and cash equivalents at beginning of period         5,158  
Cash and cash equivalents at end of period     $ 537   $ 537 $ 5,158
Financial Designation, Predecessor and Successor [Fixed List] Predecessor Successor Successor Predecessor Successor  
Predecessor [Member]            
Cash flows from financing activities:            
Cash and cash equivalents at beginning of period   $ 2,001   $ 9,746   $ 9,746
Cash and cash equivalents at end of period $ 2,001     2,001    
Successor [Member]            
Cash flows from financing activities:            
Cash and cash equivalents at beginning of period   31,238        
Cash and cash equivalents at end of period $ 31,238 $ 16,177   $ 31,238